X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
index medicus (7) 7
adult (5) 5
aged (5) 5
female (5) 5
hematology (5) 5
middle aged (5) 5
male (4) 4
prognosis (4) 4
chemotherapy (3) 3
immunophenotyping (3) 3
kaplan-meier estimate (3) 3
oncology (3) 3
phenotype (3) 3
stem-cell transplantation (3) 3
young adult (3) 3
adolescent (2) 2
aged, 80 and over (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
care and treatment (2) 2
cohort studies (2) 2
disease progression (2) 2
flow cytometry (2) 2
induction (2) 2
multiple myeloma (2) 2
predictive value of tests (2) 2
proportional hazards models (2) 2
risk factors (2) 2
time factors (2) 2
treatment outcome (2) 2
abnormalities (1) 1
acute lymphoblastic-leukemia (1) 1
acute myeloid-leukemia (1) 1
acute promyelocytic leukemia (1) 1
adults (1) 1
age factors (1) 1
aged patients (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
antineoplastic agents, alkylating - administration & dosage (1) 1
articles (1) 1
b-cells (1) 1
biomarkers (1) 1
biomarkers - analysis (1) 1
biomarkers, tumor - genetics (1) 1
biomarkers, tumor - metabolism (1) 1
bleomycin - adverse effects (1) 1
bleomycin - therapeutic use (1) 1
body regions (1) 1
bone marrow (1) 1
bone-marrow (1) 1
boronic acids - administration & dosage (1) 1
bortezomib (1) 1
cd4-cd8 ratio (1) 1
cell separation (1) 1
child (1) 1
chronic disease (1) 1
chronic lymphoproliferative disorders of nk-cells (1) 1
classification (1) 1
clinical-trials (1) 1
clonality (1) 1
clone cells - pathology (1) 1
clpd-nk (1) 1
cluster analysis (1) 1
coculture techniques (1) 1
corticosteroids (1) 1
criteria (1) 1
cytogenetics (1) 1
células matadoras naturais (1) 1
dacarbazine - adverse effects (1) 1
dacarbazine - therapeutic use (1) 1
designs (1) 1
disease (1) 1
doenças linfoproliferativas (1) 1
doxorubicin - adverse effects (1) 1
doxorubicin - therapeutic use (1) 1
drug administration schedule (1) 1
drug resistance, neoplasm (1) 1
expression (1) 1
fdg-pet (1) 1
flow cytometry - methods (1) 1
flow-cytometry (1) 1
flt3-activating mutations (1) 1
flt3-itd size (1) 1
fluorescent antibody technique (1) 1
fms-like tyrosine kinase 3 - genetics (1) 1
follow-up studies (1) 1
fusion transcript (1) 1
gene expression regulation, neoplastic (1) 1
genetic abnormalities (1) 1
health aspects (1) 1
hematology, oncology and palliative medicine (1) 1
hematopoietic stem cell transplantation (1) 1
hematopoietic stem cell transplantation - methods (1) 1
hemic and lymphatic diseases (1) 1
high-dose therapy (1) 1
hodgkin disease - drug therapy (1) 1
hodgkin disease - immunology (1) 1
hodgkin disease - mortality (1) 1
hodgkin disease - pathology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 934 - 941
Journal Article
Haematologica, ISSN 0390-6078, 05/2010, Volume 95, Issue 5, pp. 745 - 751
Journal Article
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 05/2017, Volume 58, Issue 5, pp. 1144 - 1152
Prognostic factors in Hodgkin lymphoma (HL) still fail to accurately identify high-risk patients. Tumor microenvironment in HL is a current focus of research... 
T-cell mediated immunity | Lymphoma and Hodgkin disease | lymphocytes | FDG-PET | MACROPHAGES | PROGNOSTIC SCORE | CLASSIFICATION | INDUCTION | CHEMOTHERAPY | MICROENVIRONMENT | ONCOLOGY | DISEASE | FLOW-CYTOMETRY | SELECTION | HEMATOLOGY | T-Lymphocyte Subsets - immunology | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Lymph Nodes - pathology | Prognosis | Dacarbazine - therapeutic use | Hodgkin Disease - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Young Adult | CD4-CD8 Ratio | Bleomycin - therapeutic use | Vinblastine - adverse effects | Aged, 80 and over | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Child | Kaplan-Meier Estimate | Lymph Nodes - metabolism | Immunophenotyping | Treatment Outcome | Bleomycin - adverse effects | Lymph Nodes - immunology | Phenotype | T-Lymphocyte Subsets - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | T-Lymphocyte Subsets - metabolism | Adolescent | Biomarkers | Lymphocyte Count | Hodgkin Disease - immunology | ROC Curve | Aged | Neoplasm Staging | Doxorubicin - adverse effects | Lymphocytes, Tumor-Infiltrating - immunology
Journal Article
Leukemia, ISSN 0887-6924, 05/2015, Volume 29, Issue 5, pp. 1186 - 1194
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.